M A Geyer

4.3k total citations · 1 hit paper
31 papers, 3.7k citations indexed

About

M A Geyer is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, M A Geyer has authored 31 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 6 papers in Psychiatry and Mental health. Recurrent topics in M A Geyer's work include Neurotransmitter Receptor Influence on Behavior (17 papers), Neuroscience and Neuropharmacology Research (9 papers) and Receptor Mechanisms and Signaling (7 papers). M A Geyer is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (17 papers), Neuroscience and Neuropharmacology Research (9 papers) and Receptor Mechanisms and Signaling (7 papers). M A Geyer collaborates with scholars based in United States, Netherlands and Switzerland. M A Geyer's co-authors include Neal R. Swerdlow, David Braff, Kirsten Krebs-Thomson, Vaishali P. Bakshi, Martin P. Paulus, Robert S. Mansbach, George F. Koob, Michael A. Jenkins, Joyce Sprock and J.L. Rausch and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Hypertension.

In The Last Decade

M A Geyer

31 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

2001 1.3k citations M A Geyer, Kirsten Krebs-Thomson et al. Psychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M A Geyer United States	21	2.3k	1.2k	979	552	472	31	3.7k
Patricia M. Whitaker‐Azmitia United States	35	2.1k 0.9×	1.4k 1.1×	936 1.0×	397 0.7×	855 1.8×	68	4.5k
C.L.E. Broekkamp Netherlands	37	2.4k 1.0×	1.3k 1.0×	675 0.7×	443 0.8×	667 1.4×	85	3.7k
David L. Braff United States	13	1.7k 0.7×	891 0.7×	1.2k 1.2×	849 1.5×	380 0.8×	14	3.3k
Mirjana Carli Italy	40	2.9k 1.3×	1.4k 1.1×	1.7k 1.7×	607 1.1×	455 1.0×	67	4.5k
Kurt Rasmussen United States	36	2.5k 1.1×	1.6k 1.3×	856 0.9×	404 0.7×	368 0.8×	75	4.3k
John F. Neumaier United States	37	2.6k 1.1×	1.5k 1.3×	973 1.0×	388 0.7×	703 1.5×	102	4.4k
Roberto William Invernizzi Italy	42	3.0k 1.3×	1.5k 1.2×	768 0.8×	652 1.2×	348 0.7×	100	4.4k
Anne Dekeyne France	33	2.1k 0.9×	1.3k 1.1×	502 0.5×	402 0.7×	528 1.1×	73	3.2k
Gaylord Ellison United States	38	2.6k 1.1×	1.5k 1.2×	742 0.8×	357 0.6×	454 1.0×	92	4.0k
Daina Economidou Italy	29	2.5k 1.1×	1.0k 0.8×	1.0k 1.0×	390 0.7×	375 0.8×	34	3.2k

Countries citing papers authored by M A Geyer

Since Specialization

Citations

This map shows the geographic impact of M A Geyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M A Geyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M A Geyer more than expected).

Fields of papers citing papers by M A Geyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M A Geyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M A Geyer. The network helps show where M A Geyer may publish in the future.

Co-authorship network of co-authors of M A Geyer

This figure shows the co-authorship network connecting the top 25 collaborators of M A Geyer. A scholar is included among the top collaborators of M A Geyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M A Geyer. M A Geyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Platten, Amanda, et al.. (2002). "Typical" but not "atypical" antipsychotic effects on startle gating deficits in prepubertal rats. Psychopharmacology. 161(1). 38–46. 18 indexed citations

Geyer, M A, Kirsten Krebs-Thomson, David Braff, & Neal R. Swerdlow. (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology. 156(2-3). 117–154. 1267 indexed citations breakdown →

Ralph, Rebecca J., Martin P. Paulus, & M A Geyer. (2001). Strain-Specific Effects of Amphetamine on Prepulse Inhibition and Patterns of Locomotor Behavior in Mice. Journal of Pharmacology and Experimental Therapeutics. 298(1). 148–155. 99 indexed citations

Swerdlow, Neal R., David Braff, & M A Geyer. (2000). Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behavioural Pharmacology. 11(3 & 4). 185–204. 351 indexed citations

Paulus, Martin P., Geoffrey B. Varty, & M A Geyer. (2000). The genetic liability to stress and postweaning isolation have a competitive influence on behavioral organization in rats. Physiology & Behavior. 68(3). 389–394. 17 indexed citations

Light, Gregory A., M A Geyer, Brett A. Clementz, Kristin S. Cadenhead, & David Braff. (2000). Normal P50 Suppression in Schizophrenia Patients Treated With Atypical Antipsychotic Medications. American Journal of Psychiatry. 157(5). 767–771. 177 indexed citations

Palmer, Abraham A., et al.. (2000). Prepulse startle deficit in the Brown Norway rat: A potential genetic model.. Behavioral Neuroscience. 114(2). 374–388. 17 indexed citations

Halim, Nader D., et al.. (2000). Ontogeny of Phencyclidine and Apomorphine-Induced Startle Gating Deficits in Rats. Pharmacology Biochemistry and Behavior. 65(3). 449–457. 39 indexed citations

Bakshi, Vaishali P. & M A Geyer. (1999). Ontogeny of Isolation Rearing-Induced Deficits in Sensorimotor Gating in Rats. Physiology & Behavior. 67(3). 385–392. 95 indexed citations

10.

Geyer, M A, et al.. (1999). Effects of LU-111995 in Three Models of Disrupted Prepulse Inhibition in Rats. Journal of Pharmacology and Experimental Therapeutics. 290(2). 716–724. 25 indexed citations

11.

Geyer, M A. (1999). The Effects of M100907 in Pharmacological and Developmental Animal Models of Prepulse Inhibition Deficits in Schizophrenia. Neuropsychopharmacology. 21(6). S134–S142. 23 indexed citations

12.

Swerdlow, Neal R., et al.. (1998). Towards a cross-species pharmacology of sensorimotor gating: effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats. Behavioural Pharmacology. 9(5). 389–396. 47 indexed citations

13.

Braff, David, Neal R. Swerdlow, & M A Geyer. (1995). Gating and habituation deficits in the schizophrenia disorders.. PubMed. 3(2). 131–9. 77 indexed citations

14.

Bakshi, Vaishali P. & M A Geyer. (1995). Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology. 122(2). 198–201. 163 indexed citations

15.

Markou, A., K. Matthews, David H. Overstreet, George F. Koob, & M A Geyer. (1994). Flinders resistant hypocholinergic rats exhibit startle sensitization and reduced startle thresholds. Biological Psychiatry. 36(10). 680–688. 20 indexed citations

16.

Swerdlow, Neal R., et al.. (1990). Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology. 100(3). 413–416. 215 indexed citations

17.

Gold, Lisa, G F Koob, & M A Geyer. (1990). Spatial pattern analysis reveals similarities between amphetamine conditioned and unconditioned locomotion. Behavioural Pharmacology. 1(3). 209???220–209???220. 5 indexed citations

18.

Rosenthal, J, et al.. (1990). Reninlike enzymes in human vasculature.. Hypertension. 15(6_pt_2). 848–853. 17 indexed citations

19.

Geyer, M A, Patrick V. Russo, David S. Segal, & Ronald Kuczenski. (1987). Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats. Pharmacology Biochemistry and Behavior. 28(3). 393–399. 128 indexed citations

20.

Geyer, M A, et al.. (1970). Localization of depletion-sensitive and depletion-resistant norepinephrine storage sites in autonomic ganglia.. PubMed. 174(1). 56–71. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact